Literature DB >> 29808607

Mycetoma: reviewing a neglected disease.

P Verma1, A Jha2.   

Abstract

Mycetoma caused by either filamentous fungi (eumycotic) or bacteria (actinomycotic) has recently been recognized by the World Health Organization as a neglected tropical disease. Although mycetoma is preventable and treatable, especially in the early stages, it carries high morbidity and a huge socioeconomic burden. Skin and subcutaneous tissue is affected, with a classic presentation of hard woody swellings, discharging sinuses and presence of grains (containing the causative organism). Variants with swelling without sinuses have also been described. Left untreated it may involve underlying bone and muscle, leading to permanent disability. Common actinomycotic species include Streptomyces somaliensis, Actinomadura madurae, Actinomadura pelletieri, Nocardia brasiliensis and Nocardia asteroides, while Madurella mycetomatis, Madurella grisea, Pseudoallescheria boydii and Leptosphaeria senegalensis are common eumycotic agents. Men are more commonly affected than women, and the leg is the most frequently affected site. Diagnosis in suspected lesions is made with the help of grain examination, microscopy, imaging (radiography, ultrasonography, magnetic resonance imaging) and culture, and more recently by molecular methods such as PCR and molecular sequencing. Molecular sequencing for both fungi and bacteria is important for rapid and correct diagnosis, especially in culture-negative cases. Treatment is long, more successful in actinomycetoma than eumycetoma, and may require a holistic approach comprising antimicrobials, surgery and rehabilitation. Mycetoma can be prevented by simple measures such as wearing protective garments and shoes, especially in rural areas and during outdoor activities.
© 2018 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29808607     DOI: 10.1111/ced.13642

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  11 in total

1.  Subcutaneous Mycoses in Travelers.

Authors:  Andrés Tirado-Sánchez; Carlos Franco-Paredes; Alexandro Bonifaz
Journal:  Curr Trop Med Rep       Date:  2020-11-06

Review 2.  Mycetoma: a clinical dilemma in resource limited settings.

Authors:  Pembi Emmanuel; Shyam Prakash Dumre; Stephen John; Juntra Karbwang; Kenji Hirayama
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-08-10       Impact factor: 3.944

3.  Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity.

Authors:  Małgorzata Krześniak; Artur Zajkowicz; Agnieszka Gdowicz-Kłosok; Magdalena Głowala-Kosińska; Barbara Łasut-Szyszka; Marek Rusin
Journal:  Cell Signal       Date:  2020-02-04       Impact factor: 4.315

Review 4.  Madurella mycetomatis infection of the foot: a case report of a neglected tropical disease in a non-endemic region.

Authors:  Basma Karrakchou; Ibtissam Boubnane; Karima Senouci; Badreddine Hassam
Journal:  BMC Dermatol       Date:  2020-01-10

5.  A Human Lung-Associated Streptomyces sp. TR1341 Produces Various Secondary Metabolites Responsible for Virulence, Cytotoxicity and Modulation of Immune Response.

Authors:  Andrej Herbrík; Erika Corretto; Alica Chroňáková; Helena Langhansová; Petra Petrásková; Jiří Hrdý; Matouš Čihák; Václav Krištůfek; Jan Bobek; Miroslav Petříček; Kateřina Petříčková
Journal:  Front Microbiol       Date:  2020-01-17       Impact factor: 5.640

6.  Cystic form of Actinomycotic mycetoma: A new case with a diagnostic challenge.

Authors:  Ahlem Bellalah; Nouha Ben Abdeljelil; Manel Njima; Seifeddine Ben Hammouda; Sarah Ben Khalifa; Mustapha Koubaa; Abdelfatteh Zakhama; Rim Hadhri
Journal:  Clin Case Rep       Date:  2021-03-16

7.  Actinomycetoma by Actinomadura madurae: Clinical Characteristics and Treatment of 47 Cases.

Authors:  Alexandro Bonifaz; Andrés Tirado-Sánchez; Denisse Vazquez-Gonzalez; Javier Araiza; Rigoberto Hernández-Castro
Journal:  Indian Dermatol Online J       Date:  2021-02-22

8.  Clinical epidemiological characteristics of mycetoma in Eastern Sennar locality, Sennar State, Sudan.

Authors:  Rowa Hassan; Kebede Deribe; Ahmed Hassan Fahal; Melanie Newport; Sahar Bakhiet
Journal:  PLoS Negl Trop Dis       Date:  2021-12-13

9.  Identification and antimicrobial susceptibility of Streptomyces and other unusual Actinobacteria clinical isolates in Spain.

Authors:  J A Sáez-Nieto; G Carrasco; S Del Pino; M J Medina-Pascual; N Garrido; P Villalón; S Valdezate
Journal:  New Microbes New Infect       Date:  2021-12-13

Review 10.  Clinical Features of Mycetoma and the Appropriate Treatment Options.

Authors:  Pooja Agarwal; Ashish Jagati; Santoshdev P Rathod; Kirti Kalra; Shefali Patel; Malay Chaudhari
Journal:  Res Rep Trop Med       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.